Correlation Between Orgenesis and Tff Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Orgenesis and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orgenesis and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Orgenesis and Tff Pharmaceuticals, you can compare the effects of market volatilities on Orgenesis and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orgenesis with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orgenesis and Tff Pharmaceuticals.

Diversification Opportunities for Orgenesis and Tff Pharmaceuticals

0.87

Correlation Coefficient

Orgenesis  Tff Pharmaceuticals

Very poor diversification

The 3 months correlation between Orgenesis and Tff is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Orgenesis and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Orgenesis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orgenesis are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Orgenesis i.e., Orgenesis and Tff Pharmaceuticals go up and down completely randomly.

Pair Corralation between Orgenesis and Tff Pharmaceuticals

Given the investment horizon of 90 days Orgenesis is expected to generate 1.04 times more return on investment than Tff Pharmaceuticals. However, Orgenesis is 1.04 times more volatile than Tff Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  1,960  in Orgenesis on September 22, 2024 and sell it today you would lose (1,838) from holding Orgenesis or give up 93.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	91.55%
Values	Daily Returns

Orgenesis  vs.  Tff Pharmaceuticals

Orgenesis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Tff Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Orgenesis and Tff Pharmaceuticals

The main advantage of trading using opposite Orgenesis and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orgenesis position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.

The idea behind Orgenesis and Tff Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.